A 3D Printing Based Anthropomorphic Eye Phantom Development

André Luiz Espíndola Fidelis; Dirceu Dias Pereira; Luiz Antonio Ribeiro  da Rosa; Simone Coutinho Cardoso

doi:10.15392/2319-0612.2024.2637

Authors

Andre Fidelis IRD https://orcid.org/0009-0009-0817-3735
Dirceu Dias Pereira Oncologia D'or São Cristóvão - Rede D'or São Luiz https://orcid.org/0000-0001-5262-8586
Luiz Antonio Ribeiro da Rosa IRD https://orcid.org/0000-0001-7284-1659
Simone Coutinho Cardoso IF-UFRJ https://orcid.org/0000-0001-6216-202X

DOI:

https://doi.org/10.15392/2319-0612.2024.2637

Keywords:

Anthropomorphic phantom, dosimetry, eye, 3D printing, radiotherapy

Abstract

This study aimed to construct a tissue-equivalent anthropomorphic phantom using 3D printing to enable dosimetry with radiochromic films of the optical apparatus in external beam radiotherapy. Slices were developed based on and intended to be used in conjunction with the reference phantom ATOM. 3D printing with polylactic acid (PLA) was utilized to represent soft tissues, while a mixture of gypsum, salt, and water was used as a skull bone simulator. The validation of the phantom was conducted through Hounsfield Units (HU) assessments to verify the homogeneity and compatibility with the ATOM phantom. Homogeneity was confirmed with a variation of 28.1% in the PLA component and 6.6% in the gypsum mixture. The results also demonstrated compatibility with the materials of the ATOM phantom. The phantom was successfully constructed and validated, making it suitable for testing as a dosimetric system for evaluating doses in the ocular region during radiotherapeutic procedures.

Downloads

Download data is not yet available.

References

[1] CHENG, C. Y.; HSU, Wen-Ming. Incidence of eye cancer in Taiwan: an 18-year review. Eye, v. 18, n. 2, p. 152-158, 2004. DOI: https://doi.org/10.1038/sj.eye.6700619

[2] KALIKI, S.; SHIELDS, C. L. Uveal melanoma: relatively rare but deadly cancer. Eye, v. 31, n. 2, p. 241-257, 2017. DOI: https://doi.org/10.1038/eye.2016.275

[3] AHMAD, S. M.; ESMAELI, B. Metastatic tumors of the orbit and ocular adnexa. Current opinion in ophthalmology, v. 18, n. 5, p. 405-413, 2007. DOI: https://doi.org/10.1097/ICU.0b013e3282c5077c

[4] SHIELDS, J. A.; SHIELDS, C. L.; SCARTOZZI, R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology, v. 111, n. 5, p. 997-1008, 2004. DOI: https://doi.org/10.1016/j.ophtha.2003.01.002

[5] LUCENA, E. et al. Epidemiology of uveal melanoma in Brazil. International Journal of Retina and Vitreous, v. 6, p. 1-8, 2020. DOI: https://doi.org/10.1186/s40942-020-00261-w

[6] RIBEIRO, K. C. B.; ANTONELI, C. B. G. Trends in eye cancer mortality among children in Brazil, 1980–2002. Pediatric blood & cancer, v. 48, n. 3, p. 296-305, 2007. DOI: https://doi.org/10.1002/pbc.20826

[7] THOMSON, R. M. et al. AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221. Medical Physics, v. 47, n. 5, p. e92-e124, 2020. DOI: https://doi.org/10.1002/mp.13996

[8] CHIU‐TSAO, S. et al. Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS. Medical physics, v. 39, n. 10, p. 6161-6184, 2012. DOI: https://doi.org/10.1118/1.4749933

[9] STANNARD, C. et al. Radiotherapy for ocular tumours. Eye, v. 27, n. 2, p. 119-127, 2013. DOI: https://doi.org/10.1038/eye.2012.241

[10] MUNIER, F. L. et al. New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue‐sparing techniques. Clinical & experimental ophthalmology, v. 36, n. 1, p. 78-89, 2008. DOI: https://doi.org/10.1111/j.1442-9071.2007.01602.x

[11] JEGANATHAN, V. S. E.; WIRTH, A.; MACMANUS, M. P. Ocular risks from orbital and periorbital radiation therapy: a critical review. International Journal of Radiation Oncology* Biology* Physics, v. 79, n. 3, p. 650-659, 2011. DOI: https://doi.org/10.1016/j.ijrobp.2010.09.056

[12] DURKIN, S. R. et al. Ophthalmic and adnexal complications of radiotherapy. Acta ophthalmologica Scandinavica, v. 85, n. 3, p. 240-250, 2007. DOI: https://doi.org/10.1111/j.1600-0420.2006.00822.x

[13] SCOCCIANTI, S. et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist’s guide for delineation in everyday practice. Radiotherapy and Oncology, v. 114, n. 2, p. 230-238, 2015. DOI: https://doi.org/10.1016/j.radonc.2015.01.016

[14] ABOUAF, L. et al. Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose. International Journal of Radiation Oncology* Biology* Physics, v. 82, n. 3, p. 1268-1277, 2012. DOI: https://doi.org/10.1016/j.ijrobp.2011.04.010

[15] BUTSON, M. J. et al. Measurement of radiotherapy superficial X-ray dose under eye shields with radiochromic film. Physica Medica, v. 24, n. 1, p. 29-33, 2008. DOI: https://doi.org/10.1016/j.ejmp.2007.11.001

[16] CARINOU, E. et al. Eye lens monitoring for interventional radiology personnel: dosimeters, calibration and practical aspects of Hp (3) monitoring. A 2015 review. Journal of Radiological Protection, v. 35, n. 3, p. R17, 2015. DOI: https://doi.org/10.1088/0952-4746/35/3/R17

[17] STOLARCZYK, L. et al. Assessment of undesirable dose to eye-melanoma patients after proton radiotherapy. Radiation measurements, v. 45, n. 10, p. 1441-1444, 2010. DOI: https://doi.org/10.1016/j.radmeas.2010.05.029

[18] HASANZADEH, H.; ABEDELAHI, A. Introducing a simple tissue equivalent anthropomorphic phantom for radiation dosimetry in diagnostic radiology and radiotherapy. Journal of Paramedical Sciences, v. 2, n. 4, p. 25-29, 2011.

[19] MCGARRY, C. K. et al. Tissue mimicking materials for imaging and therapy phantoms: a review. Physics in Medicine & Biology, v. 65, n. 23, p. 23TR01, 2020. DOI: https://doi.org/10.1088/1361-6560/abbd17

[20] DEWERD, L. A.; KISSICK M. The phantoms of medical and health physics. Berlin: Springer, 2014. DOI: https://doi.org/10.1007/978-1-4614-8304-5

[21] WINSLOW, J. F. et al. Construction of anthropomorphic phantoms for use in dosimetry studies. Journal of Applied Clinical Medical Physics, v. 10, n. 3, p. 195-204, 2009. DOI: https://doi.org/10.1120/jacmp.v10i3.2986

[22] MCGARRY, Conor K. et al. Tissue mimicking materials for imaging and therapy phantoms: a review. Physics in Medicine & Biology, v. 65, n. 23, p. 23TR01, 2020. DOI: https://doi.org/10.1088/1361-6560/abbd17

[23] ICRU. Report 44: Tissue Substitutes in Radiation Dosimetry and Measurement. Journal of International Commission on Radiation Units and Measurements, v. 23, 1989. DOI: https://doi.org/10.1093/jicru_os23.1.184

[24] MADAMESILA, J. et al. Characterizing 3D printing in the fabrication of variable density phantoms for quality assurance of radiotherapy. Physica Medica, v. 32, n. 1, p. 242-247, 2016. DOI: https://doi.org/10.1016/j.ejmp.2015.09.013

[25] KAMOMAE, T. et al. Three-dimensional printer-generated patient-specific phantom for artificial in vivo dosimetry in radiotherapy quality assurance. Physica Medica, v. 44, p. 205-211, 2017. DOI: https://doi.org/10.1016/j.ejmp.2017.10.005

[26] PEREIRA, D. D. et al. Validation of polylactic acid polymer as soft tissue substitutive in radiotherapy. Radiation Physics and Chemistry, v. 189, p. 109726, 2021. DOI: https://doi.org/10.1016/j.radphyschem.2021.109726

[27] PEREIRA, D. D. et al. Development of an anthropomorphic phantom based on 3D printing for assessment of dose delivered to the eye and adjacent tissues. Radiation Physics and Chemistry, v. 199, p. 110292, 2022. DOI: https://doi.org/10.1016/j.radphyschem.2022.110292

[28] PEREIRA, D. D. Desenvolvimento de um simulador antropomórfico baseado em impressão 3D para dosimetria em radioterapia de olho. Dissertação (mestrado) - Instituto de Radioproteção e Dosimetria, Rio de Janeiro, 2021.

[29] Prusa Research. Original Prusa i3 MK3S. 2019. Disponível em: https://www.prusa3d.com/category/original-prusa-i3-mk3s/. Acesso em: 10 de Junho de 2024.